Skip to content

Clinical trials

Lupus Erythematosus, Systemic trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lupus Erythematosus, Systemic Country / region: Japan Clear all

70 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20102
20114
20124
20132
20141
20151
20161
20172
20185
20195
20204
20217
20228
20235
20246
20253
20269

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed32
Active, not recruiting16
Recruiting15
Terminated5
Enrolling by invitation2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline10
AstraZeneca8
Eli Lilly and Company5
Novartis Pharmaceuticals5
AbbVie4
Bristol-Myers Squibb4
Biogen3
EMD Serono Research & Development Institute, Inc.3
Janssen Research & Development, LLC3
Eisai Co., Ltd.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lupus Erythematosus, Systemic70
Autoimmune Diseases7
Connective Tissue Diseases6
Immune System Diseases6
Arthritis, Rheumatoid5
Lupus Erythematosus, Cutaneous5
Lupus Erythematosus, Discoid4
Lupus Nephritis4
Myositis2
Arthritis1

Trials

Showing 1 to 25 of 70. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.